Neoplasms and Digestive System Diseases

The Beskidzkie Centrum Onkologii Szpital Miejski Im. Jana Pawla II W Bielsku-Bialej SPZOZ is running studies focused mainly on cancer, especially tumors of the stomach and gastroesophageal junction. These trials are designed to assess new treatment options, compare outcomes such as survival, and improve care for people with advanced or hard-to-treat disease.

  • Gastric cancer and advanced metastatic gastric cancer research aimed at improving treatment effectiveness
  • Gastroesophageal junction adenocarcinoma studies exploring targeted and immune-based therapies
  • HER2-positive gastric or GEJ cancer trials evaluating new combinations for better disease control
  • Claudin18.2 and FGFR2b biomarker-driven research to match treatments more precisely

Overall, this research area reflects a strong focus on finding more effective therapies for digestive tract cancers, with attention to survival, response to treatment, and personalized care.

Breast Cancer Research

Clinical trials at this site also include ER+/HER2- breast cancer, with an emphasis on early-stage disease. The studies are intended to test whether newer treatment approaches can improve long-term outcomes and reduce the risk of recurrence.

  • ER+/HER2- breast cancer studies focused on treatment effectiveness in high-risk patients
  • Research evaluating whether adding new therapies can improve disease control after standard care
  • Outcome measures centered on survival and prevention of cancer return

This work supports more tailored treatment strategies for breast cancer patients, especially those with aggressive or higher-risk features.

Head and Neck and Bladder Cancer

The site is also involved in trials for head and neck squamous cell carcinoma and muscle invasive bladder cancer. These studies are examining whether newer therapies can improve outcomes after standard local treatment or around surgery.

  • Head and neck cancer research testing sequential treatment after chemoradiation
  • Muscle invasive bladder cancer studies assessing perioperative treatment approaches
  • Trials focused on extending disease control and improving survival after standard therapy

At Katedra i Klinika Onkologii, these studies reflect a broader effort to refine treatment for difficult solid tumors using both established and emerging oncology approaches.

Solid Tumors and Experimental Oncology

Some trials at this research site include patients with relapsed or refractory solid tumors, showing interest in broader experimental cancer treatment options beyond one disease area. These studies are designed to evaluate safety, tolerability, and early signs of anti-tumor activity for new therapies.

  • Relapsed and refractory advanced solid tumors studies in patients with limited standard options
  • Early-phase research focused on safety and tolerability
  • Exploratory evaluation of whether new agents may slow tumor growth

This line of research helps expand treatment possibilities for patients with advanced cancer who need alternatives after standard therapies have been used.